Latest filing: GKB Ophthalmics Ltd - 533212 - Board Meeting Intimation for Approval Of Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026
ObservedCompany dossier
GKB Ophthalmics
BSE:GKB · ISIN INE265D01015
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
GKB Ophthalmics
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 51.15% and public 48.85% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing GKB Ophthalmics Ltd - 533212 - Board Meeting Intimation for Approval Of Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026
BSE · financial results
Observed
Source filing GKB Ophthalmics Ltd - 533212 - Disclosure Of Information Pursuant To Regulation 30- Update On Case No. 32/09 Filed For Adjudication Of Charter Of Demands
BSE · exchange filing
Observed
Source filing GKB Ophthalmics Ltd - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 51.15%
- Public
- 48.85%
- Employee trust
- N/A
Observed BSE shareholding XBRL